KBLB Kraig Biocraft Laboratories, Inc.

Overview and Growth

Fiscal 2025 results for Kraig Biocraft Laboratories, Inc. included net loss of $3.62M. The company reported diluted EPS of $0.00, adding a shareholder-level measure to the absolute income figures considered below. A diluted share base of 1.06B links the aggregate earnings figure to diluted EPS and helps frame the per-share comparison. Compared with 1.04B diluted shares in fiscal 2024, the current 1.06B base was 2.0% higher. Total assets stood at $2.57M, showing the scale of resources supporting revenue, earnings, liquidity, and financing.

Profitability

The reported operating result was an operating loss of $3.37M, reflecting costs that exceeded gross profit. After all below-operating-line items, the company recorded a net loss of $3.62M for the fiscal year. Negative EBITDA totaled $3.35M, confirming that the earnings deficit remained before depreciation and amortization. The company reported a pretax loss of $3.62M, before the effect of income taxes. Relative to total assets, the net loss represented 141.2%. Compared with a $3.40M net loss in fiscal 2024, the current loss increased to $3.62M.

Liquidity and Capital Structure

Total assets were $2.57M, supported by $10.56M of liabilities and -$8.00M of shareholder equity. With total equity at -$8.00M, the company carried a negative book-capital position, increasing its reliance on liabilities and future earnings. Current assets were $1.87M against $10.45M of current liabilities, framing the resources and obligations classified within the near-term balance-sheet horizon. At 0.18x, current liabilities exceeded current assets and placed pressure on the company’s near-term liquidity position. Reported cash and equivalents were $1.79M, separating immediately recognizable cash resources from the rest of the current-asset base. The cash balance equaled 17.1% of current liabilities, showing how much near-term coverage came from cash alone. The equity-to-assets relationship was -311.8%, placing book capital against the total resource base. Liabilities represented 411.8% of total assets, quantifying the liability-funded share of the company’s resource base. Cash and equivalents equaled 69.8% of total assets, showing the liquid cash component within the company’s broader resource base. The asset base changed 70.4% from $1.51M in fiscal 2024, leaving current total assets higher year over year. Compared with $673.26K in fiscal 2024, the current cash balance moved 165.9% and finished higher.

Cash Flow and Earnings Quality

Operating activities used $1.79M of cash, resulting in an operating cash outflow for the year. Capital expenditures used $5.39K in addition to the operating cash outflow, increasing the total cash consumed by operations and investment during the period. Operating cash flow and capital spending combined to leave a $1.79M cash deficit after capital spending. The cash deficit after capital spending represented 69.9% of the period-end asset base. Compared with a $1.84M operating cash outflow in fiscal 2024, the current outflow improved to $1.79M.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Oct 21, 2026.